Medical instrument manufacturing specialist Oury Medical has acquired Céfiméca, an orthopedic implant and spinal instrument maker. Terms of the deal were not disclosed.

The transaction represents a new major step in Oury Medical Group’s development and is consistent with the long-term industrial strategy initiated by TAG Partners upon Oury-Guyé’s purchase three years ago. “This acquisition marks an important step in the execution of our strategy,” Oury Medical Group CEO Sébastien Meunier stated. “By integrating complementary capabilities in instrumentation and a focused and high-value range of implants, we further strengthen the value we bring to our clients, while remaining focused on our industrial DNA.”

Since this founding acquisition, TAG Partners has actively supported the Group’s transformation with a clear ambition: to build a leading player in orthopedic and spinal medical instrumentation by aggregating complementary high-value-added manufacturing expertise. This strategy has been executed through a series of targeted acquisitions. The Céfiméca deal constitutes the fifth build-up operation executed since Oury Medical launched the platform strategy.

Céfiméca boasts expertise in orthopedic and spinal instruments, and that knowledge is complemented by a focused, high-value range of implants created through precision manufacturing. Céfiméca’s expertise strengthens Oury Medical’s capabilities as a partner offering a fully integrated one-stop shop in orthopedic medical instrumentation manufacturing.

“For more than 25 years, Céfiméca has developed strong expertise in orthopedic and spinal instruments and implants. Joining Oury Medical allows us to leverage complementary capabilities and to continue our development within a broader and more ambitious industrial platform,” Céfiméca Chairman Frédéric Mazenod said.

The acquisition is being funded by TAG Partners and ISALT, an independent French asset management company, as well as several family offices and private investors. This financing aims to bankroll the Group’s latest purchase (Céfiméca) and strengthen its balance sheet, thus continuing investments in technology, industrial capacities, and growth.

“When we acquired Oury-Guyé three years ago, our ambition was clear: to build a leading French industrial platform in orthopedic and spinal medical instrumentation through a disciplined build-up strategy,” TAG Partners Founding Partners Georges-Alexandre Ancenys, Thierry Manceau, and André Wagner commented. “Since then, we have completed five acquisitions to progressively assemble complementary know-how. The acquisition of Céfiméca fully fits within this vision and further strengthens Oury Medical’s positioning as a strategic partner for our orthopedic clients with a one-stop shop offering.”

Oury Medical is an independent French group, specialized in manufacturing surgical instruments for orthopedics and spine. With more than 100 years of expertise, the Group supports its clients from design to production of standard and custom instruments. Oury Medical has five production sites and a 200-plus workforce, and offers a one-stop solution approach to product design, manufacturing, kitting, and rekitting of complete trays, as well as maintenance and management of instruments throughout their lifecycle.

Céfiméca specializes in manufacturing of high-precision surgical instruments and orthopedic implants. The company supports its clients from prototype to serial production for numerous joint applications. Céfiméca operates two production sites in Saint Étienne and its surrounding area and stands out for its requirements in terms of quality, regulatory compliance, and customer service. It relies on recognized know-how in precision mechanics and a continuous improvement approach.

TAG Partners is an independent investment firm operating under an independent sponsor model co-founded and led by Ancenys, Manceau, and Wagner. Is supports high-potential French SMEs in ownership transition, transformation, and growth. The founding partners combine CEO and investor experience to lead value creation and transition projects around three priority areas: Operational transformation (strengthening teams and reorienting the organization towards a new phase of development); Strategic build-ups (strengthening positioning in the value chain and expanding the product offering); and Commercial development (activating local and international growth levers). TAG Partners brings together for each investment a pool of co-investors (entrepreneurs, family offices, sector experts) to create a dynamic of exchange and co-construction with companies’ management teams.